Ticker Symbol: ADMS
Adamas Pharmaceuticals Inc
$8.15 - 17-09-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001328143
Company Profile
Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 1900 Powell St Ste 1000
Website: www.adamaspharma.com
CEO: Neil McFarlane
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
$0.06
(
0.73%)
Days Range: $8.22 - $8.22
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.73%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 45786965
Valuation
Market Cap: 37.6B
PE Ratio: -5.07
EPS (TTM): -1.62
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A